Analysis of Prologis, Inc.’s Q3 2026 10-Q
Filing dated 28 October 2026 for the quarter ended 30 September 2026
Where the filing and the story diverge
Prologis is in good accounting health: occupancy 95.5%, rents on renewal up 38%, operating cash flow up 14% and debt about 95% fixed-rate. The questions are about what flatters the headline and what comes next: nine-month pre-tax earnings rose 50% but Core FFO only 9%, because of $783.6M of sale gains and a swing to FX and derivative gains; and the SEGRO combination brings a £3.575B bridge loan and continued equity issuance, including a new $5B at-the-market programme.
- Three findings: Pre-tax earnings up 50%, Core FFO up 9%; SEGRO: a £3.575B bridge loan and a new $5B share-issuance programme; Strategic capital revenue up 29% on promote-sensitive fees, and G&A up 16%. Each is set out below with the figure, where it sits in the filing and what would close it.
- On the calls. 1 of 3 findings were sidestepped or never asked.
- What it does not show. Nothing here shows a misstatement.
- Q3 revenue
- $2,387.5M
- Occupancy
- 95.5%
- Same-store NOI, nine months
- +6.4% net effective
- Core FFO, nine months
- $4,544M, up 9%
- Total debt
- $36,832.5M, ~95% fixed
Area by area: what is solid and what is stretched
Prologis’s operations, leasing and debt profile are strong. The questions sit in how sale and FX gains flatter GAAP earnings, the cost of financing SEGRO, and irregular fee income.
Three findings, ranked by importance
Each is set out in full below: what the filing shows, the numbers, the evidence and what would close it.
Pre-tax earnings up 50%, Core FFO up 9%
Nine-month earnings before tax rose to $3,302.8M from $2,204.4M. Gains on dispositions of $783.6M and FX, derivative and other gains of $218.8M (against a $53.5M loss a year earlier) explain much of it; Core FFO, which strips both, rose about 9% to $4,544M.
Disposition proceeds jumped to $1,531.9M from $340.9M, and gains on selling developed properties and land are part of Prologis’s business model, so they are not one-offs in the usual sense. But they are lumpy and depend on the transaction market, which management said it expects to moderate. FX and derivative results swung by about $272M year on year (our calculation). Core FFO is the cleaner measure of the recurring business; operating cash flow was 0.97 times Core FFO.
10-Q income statement and the Core FFO reconciliation in MD&A.
SEGRO: a £3.575B bridge loan and a new $5B share-issuance programme
SEGRO shareholders approved the combination on 28 September, with closing expected in H1 2027. Prologis raised about $2.4B of common equity in the quarter for the deal, has £3.575B of bridge commitments, and filed a new $5B at-the-market programme on 30 October.
Total debt was $36,832.5M at a 3.2% average rate and 7.9-year term, and net debt was about 5.3 times our annualised EBITDA proxy (our calculation, based on segment NOI less G&A). The bulk of the consideration is a share exchange, so dilution, not leverage, is the main financial effect, and the new ATM adds to that. How much of the bridge is drawn at closing, and what replaces it, is not yet disclosed. Prologis also closed about $1.3B of debt financing in the quarter at just under 4%, above its 3.2% average, so new debt costs more than the existing book.
10-Q subsequent events and debt note; Exhibit 10.2 for the bridge; the call for the equity raise and financing.
Strategic capital revenue up 29% on promote-sensitive fees, and G&A up 16%
Strategic capital revenue rose to $566.8M from $438.7M, led by Other Americas at $153.4M against $65.9M, which is sensitive to promote and transaction fees. G&A rose 15.6% to $384.1M against revenue growth of 8.8%.
Promotes are performance fees earned when a fund beats its targets; they are real income but irregular, so a year with large promotes sets a high base for the next. Management cut its guide for strategic capital revenue excluding promotes to $650M to $660M, citing a tempered view on asset management fees and the timing of transaction fees. G&A is guided at $515M to $525M for the year, and some of its growth may relate to SEGRO preparation, which the filing does not separate.
10-Q segment note; the call for guidance.
Other findings, checked and set aside
Each item was tested against the filing. None changes the lead findings above.
| Item | What the filing shows, and why it is not a lead finding |
|---|---|
| Two filers in one 10-Q | Prologis, Inc. and Prologis, L.P. report together, with parallel tags for each; values reconcile between them. |
| XBRL: 173 custom elements | All 53 monetary custom tags tie to printed captions; no mismatches found. |
| One equity raise, not two | The $2.4B raised in Q3 is the main part of the $2,411.4M issued in nine months; it is not an additional raise after the quarter. |
| Core FFO reconciliation | Disposition gains of $783.6M and FX and derivative results are excluded from Core FFO as described. |
| Acquisition accounting | SEGRO had not closed by 30 September, so no purchase accounting applies yet. |
| Not disclosed in the 10-Q | Litigation, government incentives and new accounting standards: none of note found. |
What management said about each finding
Management guided both measures, saying “we expect net earnings to range between $4.05 and $4.15 per share, and core FFO is expected to range between $6.25 and $6.29 per share”, but neither the disposition gains nor the FX and derivative swing came up.
The CFO said “the vast majority of the capitalization of this transaction is known and certain. It's broadly the share exchange. Thereafter, we've done an equity raise that we've tucked away for this eventual closing”, but gave no detail on the bridge draw or take-out, citing the regulatory process.
The CFO revised strategic capital revenue excluding promotes to $650M–$660M, “reflecting a tempered view on asset management fees, as well as the timing of some transaction-based fees”, and guided G&A to $515M–$525M; the G&A increase itself was not explained.
7 disclosures moved
10-Q Q3 2026 compared with the 10-K for 31 December 2025.
| Status | Disclosure | Before | Now |
|---|---|---|---|
| New | SEGRO combination Approved by SEGRO shareholders 28 September | Not present | Closing expected H1 2027 |
| New | Bridge term loan Exhibit 10.2 | None | £3.575B of commitments |
| Changed | Common equity issued Nine months 2026 vs 2025 · cash flow statement | Minimal | $2,411.4M, mostly the Q3 raise |
| New | At-the-market programme Form 8-K, 30 October | 2020 programme | New $5B programme |
| Changed | Disposition proceeds Nine months 2026 vs 2025 | $340.9M | $1,531.9M |
| Changed | Assets held for sale Note 4 | $203.3M | $545.8M |
| Changed | Cash Balance sheet | $1,145.6M | $2,273.5M |
A recommended combination with SEGRO, a large equity raise and new share-issuance capacity, more property sales and higher guidance for development.
5 markers for 20 January
Set before the numbers, so the read can be checked afterwards.
| Marker | Now | Gap widens if | Gap closes if | Result |
|---|---|---|---|---|
| Core FFO guidance | $6.25–$6.29 per share for 2026 | Full-year Core FFO lands below $6.25 | Within or above the range | Awaiting |
| GAAP vs Core FFO gap | Pre-tax +50% vs Core FFO +9% (nine months) | Disposition or FX gains again drive most of GAAP growth | The two growth rates converge | Awaiting |
| SEGRO financing | £3.575B bridge; $5B ATM filed | The bridge is drawn without a disclosed take-out, or ATM issuance accelerates before closing | Permanent financing is disclosed | Awaiting |
| Strategic capital revenue excluding promotes | Guided at $650M–$660M for 2026 | Below the guide | Within or above the guide | Awaiting |
| Occupancy | 95.5% at period end | Falls below the 95.25% low end of the average guide | Holds at 95.25% or above | Awaiting |
These are monitoring checks for the Q4 results, expected in late January 2027, not forecasts of a loss or breach.
6 questions, checked against the call
Raised by the 10-Q. To be tested again at Q4 results (estimated date) on 20 January.
What this does and does not show
Assets held for sale nearly tripled
16 properties (3.8M sq ft) were held for sale at $545.8M, against 10 properties at $203.3M in December; still only about 0.5% of total assets.
Not raised on the call.
What would resolve this: Sales close near book value.
Development commitments
The development portfolio has a total expected investment of $6.1B and is 34.8% leased; $884.0M of equity commitments to ventures are outstanding.
Management raised development-start guidance to $6B–$6.75B, mostly build-to-suits.
What would resolve this: Leasing of the pipeline rises.
Embedded rent growth
In-place rents are about 16% below market, and management put embedded NOI at spot rents at about $780M, a buffer if leasing slows.
Discussed on the call.
What would resolve this: Rent change on rollover stays positive.
Nothing here shows a misstatement.
Leasing, occupancy and the debt profile are strong, gains are disclosed and excluded from Core FFO, and the SEGRO financing is in progress.
- Core FFO lands within the guide
- GAAP and Core FFO growth converge
- SEGRO financing is disclosed in full
- Strategic capital holds up without promotes
- Guidance is cut
- Gains keep carrying GAAP growth
- Bridge drawn without a take-out plan
- Heavy ATM issuance before closing
Every figure ties back to the filing
| Prologis Form 10-Q, quarter ended 30 September 2026 | Open ↗ |
| Q3 2026 earnings call | Third-party transcripts |
| Exhibit 10.2, SEGRO bridge term loan | Filed with the SEC |
| Form 8-K, at-the-market programme, 30 October 2026 | Filed with the SEC |
Helmledgers reads the full filing, including the notes, and ties every figure to the statement or note it comes from, with each number re-checked against the source before release. This is an accounting read of public SEC filings, not an audit opinion and not investment advice.
- Severity
- High: material effect on cash, debt or reported results. Medium: worth tracking, smaller or less certain effect.
- On the call
- Direct answer, Partly answered (topic addressed, figure missing), Sidestepped (raised but not answered) or Not asked.
- Since the read
- Confirmed by a later disclosure, Escalated (grown since), Open (untested) or Missed (not flagged by the read).
- Said versus done
- Kept, Slipped (late), Changed (plan or terms changed), Missed or Reversed.
- Markers
- Measurable checks set before results, each with what would widen or close the gap. Scored after the next results.
- Closes if
- The evidence that would resolve a finding.
Helmledgers and its analysts hold no position in Prologis (PLD) securities.
This is an accounting read of public SEC filings. It is not an audit opinion and not investment advice.